ISRG 8-K Current Reports
INTUITIVE SURGICAL INC - 210 current reports
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 28, 2026)
Intuitive Surgical, Inc. (ISRG) announced a significant leadership transition effective July 1, 2026. Henry L. Charlton will be stepping down from his position as Chief Commercial and Marketing Officer to assume a new role as Senior Vice President of Global Business Operations. This move suggests a strategic reallocation of experienced leadership within the company to focus on operational efficiency and global business expansion. Taylor Patton, currently Global Senior Vice President of Endoluminal, will be promoted to Chief Commercial and Marketing Officer, succeeding Mr. Charlton. This internal promotion indicates continuity in leadership and confidence in Ms. Patton's ability to drive the company's commercial and marketing strategies. Investors should monitor how these leadership changes impact the company's go-to-market strategies and overall business growth in the upcoming fiscal periods.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 4, 2026)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on May 4, 2026, reporting on key outcomes from its Annual Meeting of Stockholders held on April 30, 2026. The primary focus for investors is the approval of an amended and restated 2010 Incentive Award Plan, which increases the share reserve by 5 million shares, extends the plan's term to January 2036, and clarifies change-in-control provisions. This demonstrates a continued commitment to employee and executive compensation through equity, a common practice for growth-oriented companies. Furthermore, the filing details the successful election of all ten director nominees, indicating shareholder confidence in the current board's leadership. Stockholders also provided advisory approval for executive compensation and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. In a significant move for capital allocation, the company announced on April 30, 2026, that its Board of Directors increased the authorized amount available under its common stock repurchase program to an aggregate of $5.0 billion, signaling a strong belief in the company's valuation and a commitment to returning capital to shareholders.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 21, 2026)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on April 21, 2026, to announce its financial results for the first quarter ended March 31, 2026. The key details of these results are presented in an accompanying press release furnished as Exhibit 99.1. Investors should note that the information within this 8-K, including the press release, is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act, meaning it does not carry the same liabilities and is not automatically incorporated by reference into future SEC filings.
INTUITIVE SURGICAL INC 8-K Report, Corporate Update (Mar 2, 2026)
Intuitive Surgical, Inc. (ISRG) announced on March 2, 2026, the successful completion of its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. This strategic acquisition, finalized on March 1, 2026, is expected to enhance the company's market presence and distribution capabilities within the regions served by these entities. This move signals Intuitive Surgical's commitment to expanding its global reach and strengthening its sales and support infrastructure for its robotic surgical systems. Investors should monitor the integration process and any potential financial impacts, as this acquisition could contribute to future revenue growth and market share gains.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 22, 2026)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on January 22, 2026, primarily to furnish a press release detailing its financial results for the quarter ended December 31, 2025. While the full financial details are within the press release (Exhibit 99.1), the filing itself does not contain new operational or financial data beyond referencing this external announcement. Investors should refer to the press release for specific performance metrics, revenue figures, and any forward-looking statements or guidance provided by the company. This filing serves as a notification to the market that the company's fourth-quarter and full-year 2025 financial results are now publicly available. The 8-K format indicates that this information is being disclosed in accordance with regulatory requirements, but the company has stipulated that this information is furnished and not deemed "filed" for purposes of certain securities laws, limiting its incorporation by reference into other SEC filings.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 14, 2026)
Intuitive Surgical, Inc. (ISRG) has filed a Current Report on Form 8-K on January 14, 2026, to announce preliminary, unaudited financial results for the fourth quarter and full year of 2025. The report indicates that a press release (Exhibit 99.1) has been issued detailing these results, along with additional preliminary revenue and procedure information (Exhibit 99.2) that has also been made available on the company's Investor Relations website. Investors should note that this information is preliminary and furnished, not filed, meaning it is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Dec 18, 2025)
Intuitive Surgical, Inc. (ISRG) has announced a leadership transition effective January 1, 2026. Brian E. Miller, Ph.D., will be stepping down as Chief Digital Officer. While this role change might initially suggest a shift in focus, Dr. Miller will remain with the company in a newly created position: Head of Digital and AI Strategy. This move indicates a continued commitment to advancing the company's digital and artificial intelligence initiatives, albeit with a restructured reporting line.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 21, 2025)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on October 21, 2025, to announce its financial results for the quarter ended September 30, 2025. The primary purpose of this filing is to furnish a press release containing these results, which was issued on the same date. Investors should refer to the attached press release (Exhibit 99.1) for detailed financial performance and operational updates for the period. While the 8-K itself does not contain the specific financial figures, it serves as the official notification that these results are now public. The company has provided standard disclosures regarding the informational status of this filing, clarifying that it is furnished and not deemed "filed" under Section 18 of the Exchange Act. This means the information is for disclosure purposes and does not carry the same legal implications as a formally filed document in that regard.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 22, 2025)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on July 22, 2025, to announce its financial results for the quarter ended June 30, 2025. The primary purpose of this filing is to furnish a press release that details the company's performance and financial condition for the period. Investors should refer to the press release (Exhibit 99.1) for specific details regarding revenue, profitability, procedure volumes, and any forward-looking statements or guidance provided by the company. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification mechanism for the release of this information. The furnished press release is the key document for understanding ISRG's operational and financial results for the second quarter of 2025, offering insights into the continued adoption and utilization of their robotic surgical systems. Investors are encouraged to review the full press release for a comprehensive understanding.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 15, 2025)
Intuitive Surgical, Inc. (ISRG) announced significant leadership changes effective July 1, 2025. David J. Rosa, currently President, will be appointed Chief Executive Officer, succeeding Dr. Gary S. Guthart. Dr. Guthart will transition to the role of Executive Chair of the Board, retaining his director position. Craig H. Barratt, Ph.D., current Board Chair, will assume the role of lead independent director. These changes reflect a planned succession and aim to leverage Mr. Rosa's extensive experience within the company for future growth. In conjunction with these transitions, compensation adjustments have been made. Mr. Rosa's base salary will increase, and his bonus target will be enhanced, alongside significant equity awards in the form of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs). Dr. Guthart's compensation will be adjusted to reflect his new role as Executive Chair and senior advisor, with a reduced base salary and no bonus eligibility going forward, though he will receive a pro-rated bonus for fiscal year 2025. These moves are designed to ensure a smooth leadership transition and align executive incentives with the company's strategic objectives.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 5, 2025)
Intuitive Surgical Inc. (ISRG) filed an 8-K report detailing outcomes from their Annual Meeting of Stockholders held on May 1, 2025, and an increase in their stock repurchase program. Key among the meeting's outcomes was the stockholder approval of the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. This amendment increases the number of shares reserved for issuance by 5 million, extends the plan's term to January 30, 2035, and clarifies treatment of awards in change-in-control scenarios. Additionally, all eleven director nominees were elected to the Board, and advisory approval was given for executive compensation. Further enhancing shareholder value initiatives, the Board of Directors approved an increase to the common stock repurchase program by $4.0 billion, encompassing previously authorized but unused amounts. This signifies management's confidence in the company's financial health and commitment to returning capital to shareholders. While most proposals passed with strong support, two shareholder proposals concerning executive compensation and golden parachutes were rejected by a significant margin.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 22, 2025)
Intuitive Surgical, Inc. (ISRG) has filed a Form 8-K on April 22, 2025, to report on its financial results for the quarter ended March 31, 2025. The primary purpose of this filing is to furnish a press release containing these results, which was issued on the same day. Investors should refer to this press release (Exhibit 99.1) for detailed information on the company's performance during the first quarter of fiscal year 2025. While the 8-K itself is brief and primarily an informational filing vehicle for the press release, the attached press release is expected to contain key financial metrics such as revenue, earnings per share, and potentially procedural volumes. Investors are advised to analyze these results carefully to understand the company's growth trajectory, operational efficiency, and overall financial health in the context of the current market and competitive landscape. The filing also clarifies that the information furnished is not considered 'filed' for Section 18 purposes, a standard disclaimer for such reports.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 23, 2025)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on January 23, 2025, announcing its financial results for the quarter ended December 31, 2024, in an accompanying press release (Exhibit 99.1). While specific financial figures from the earnings release are not detailed in the 8-K itself, this filing signals the release of their latest quarterly performance data to the public. Investors should refer to the furnished press release for a comprehensive understanding of ISRG's financial condition and operational results for the period. In addition to financial results, the 8-K also disclosed a significant strategic acquisition. On January 21, 2025, Intuitive announced a definitive agreement to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, and San Marino from current distributors ab medica, Abex, and Excelencia Robotica. This acquisition involves an upfront cash payment of approximately €290 million, with potential for an additional €31 million in milestone payments. The transaction is expected to close in the first half of 2026, subject to customary conditions, and represents a move to strengthen ISRG's direct control over key European distribution channels.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 15, 2025)
Intuitive Surgical, Inc. (ISRG) has filed a Form 8-K report on January 15, 2025, announcing unaudited preliminary financial results for the fourth quarter and full year of 2024. This filing serves to provide investors with early insights into the company's performance ahead of more detailed reporting. The report primarily consists of a press release and supplementary tables containing preliminary revenue and procedure data. While these results are preliminary and unaudited, they offer investors a glimpse into the company's operational and financial trajectory for the period. The company has furnished these documents, making them available to the public through the filing and its Investor Relations website, underscoring a commitment to transparency.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Jan 6, 2025)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report detailing significant executive promotions effective January 1, 2025. Jamie E. Samath has been elevated to Executive Vice President, Chief Financial Officer, and Head of Business Technology. Concurrently, Henry L. Charlton has been promoted to Executive Vice President, Chief Commercial and Marketing Officer. These appointments signify a recognition of their contributions and likely reflect a strategic alignment within the company's leadership structure as it continues to navigate the evolving landscape of robotic-assisted surgery.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 17, 2024)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on October 17, 2024, to announce its financial results for the quarter ended September 30, 2024. The key information is contained within the furnished press release (Exhibit 99.1), which provides the company's performance details for the period. Investors should refer to this press release for specifics on revenue, profitability, and any other significant operational metrics. While the 8-K itself does not contain the financial figures, it formally incorporates the press release which serves as the primary source of updated financial information. It's important to note that this information is furnished and not deemed 'filed' for certain regulatory purposes, a standard disclosure for such filings.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Jul 25, 2024)
Intuitive Surgical, Inc. (ISRG) has announced a significant update to its Board of Directors. Effective July 24, 2024, David J. Rosa has been appointed as a new member to the Board. This appointment also coincides with an increase in the authorized number of Board members to 12, indicating a strategic expansion of its governance structure. Mr. Rosa's appointment does not involve any disclosable material interests, ensuring a clean transition. The company further disseminated this news through a press release on July 25, 2024. This move suggests a potential focus on strengthening strategic oversight and leadership as the company continues to innovate and grow within the robotic-assisted surgical market.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 18, 2024)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on July 18, 2024, to announce its financial results for the second quarter ended June 30, 2024. The report primarily consists of a press release detailing these results, which is furnished as Exhibit 99.1. Investors should note that this information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities and is not automatically incorporated into other SEC filings. While the 8-K itself is a procedural filing, the attached press release contains the crucial financial and operational updates. Investors will need to refer to Exhibit 99.1 for specific details on revenue, earnings, procedure volumes, and any forward-looking guidance provided by the company. This filing serves as the official notification of the company's performance during the recently concluded quarter.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Apr 30, 2024)
Intuitive Surgical, Inc. filed an 8-K report on April 29, 2024, detailing key events from its Annual Stockholders' Meeting held on April 24, 2024. The primary focus for investors is the outcome of the shareholder votes, which saw all incumbent directors re-elected and approval of executive compensation on an advisory basis. Significant governance changes include the appointment of Lewis Chew as the new Chair of the Audit Committee and Jami Dover Nachtsheim as the new Chair of the Governance and Nominating Committee. Investors will also note the approval of the amendment and restatement of both the 2010 Incentive Award Plan and the 2000 Employee Stock Purchase Plan, indicating continued support for the company's equity incentive structures. The ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2024 reinforces auditor confidence. Importantly, a shareholder proposal requesting a racial and gender pay gap report was narrowly rejected, highlighting ongoing discussions around corporate social responsibility metrics.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 18, 2024)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on April 17, 2024, to announce its financial results for the quarter ended March 31, 2024. The key details of these results are provided in a press release furnished as Exhibit 99.1 to the filing. Investors should refer to this press release for specific financial performance metrics, including revenue, profit, and operational updates related to their robotic-assisted surgical systems.
INTUITIVE SURGICAL INC 8-K Report, Regulation FD Disclosure (Mar 14, 2024)
Intuitive Surgical, Inc. (ISRG) has announced a significant development with the U.S. Food and Drug Administration (FDA) clearance of its fifth-generation robotic system, the da Vinci 5. This clearance represents a key milestone for the company, signaling the introduction of its latest technological advancements in robotic-assisted surgery to the market. Investors should pay close attention to the upcoming teleconference scheduled for March 18, 2024. This event will provide detailed insights into the da Vinci 5's new features, its expected benefits for surgical procedures, and the company's strategic launch plans. The availability of a webcast and replay ensures accessibility for all interested parties, offering an opportunity to gain a deeper understanding of how this new system might impact ISRG's future growth and competitive positioning.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 23, 2024)
Intuitive Surgical, Inc. (ISRG) has filed a Form 8-K on January 23, 2024, to report its financial results for the fourth quarter and full year ended December 31, 2023. The filing primarily contains a press release detailing these results, which is furnished as Exhibit 99.1. This report signals the company's performance in the most recent fiscal period, offering investors key insights into revenue, profitability, and operational achievements. Investors should refer to the furnished press release for the specific financial figures and management commentary. While the 8-K itself does not contain the detailed financial statements, it serves as the official notification of the release of this information. The press release is expected to cover important metrics such as system placements, procedure volumes, and the performance of their various product lines, which are crucial for understanding ISRG's growth trajectory and market position in the robotic-assisted surgery sector. The furnished information is not considered "filed" for the purposes of Section 18 of the Exchange Act.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 9, 2024)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on January 9, 2024, to announce preliminary, unaudited financial results for the fourth quarter and full year of 2023. The filing includes a press release and supplementary tables detailing revenue and procedure information, which are furnished but not deemed "filed" under SEC regulations. Investors should refer to the furnished exhibits for specific financial figures and operational metrics, as these provide an early look at the company's performance leading into its official earnings release.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Oct 31, 2023)
Intuitive Surgical, Inc. (ISRG) announced a key board appointment and related compensation details in its latest 8-K filing. Sreelakshmi Kolli has been appointed to the Board of Directors, effective October 27, 2023. This appointment also led to an increase in the authorized board size to 12 members. Ms. Kolli's compensation includes an annual cash retainer, stock options, and restricted stock units, with grant values and vesting schedules detailed in the filing.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 19, 2023)
Intuitive Surgical, Inc. (ISRG) announced its financial results for the quarter ended September 30, 2023, via a press release filed on October 19, 2023. While the 8-K filing itself does not contain the detailed financial figures, it serves as notification that the company has issued its earnings release. Investors should refer to the furnished press release (Exhibit 99.1) for specific operational and financial performance data, including key metrics like robot system placements, procedure volumes, and revenue generated during the third quarter of 2023. This filing is primarily procedural, indicating the official release of the company's quarterly performance. The press release will contain the crucial information regarding the company's top-line growth, profitability, and any forward-looking statements or guidance provided by management. Investors are advised to carefully review the full press release for a comprehensive understanding of the company's current financial health and future outlook.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 20, 2023)
Intuitive Surgical, Inc. (ISRG) announced its financial results for the second quarter ended June 30, 2023, via a press release filed on July 20, 2023. This filing provides investors with the company's latest operational and financial performance update. While the 8-K itself does not contain the detailed financial figures, it directs investors to the furnished press release (Exhibit 99.1) for these critical data points, including revenue, earnings, and operational metrics. Investors should refer to this press release for a comprehensive understanding of the company's performance during the reported quarter.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 16, 2023)
Intuitive Surgical, Inc. (ISRG) has announced a key executive leadership change via an 8-K filing on May 16, 2023. David J. Rosa has been promoted to President, effective May 16, 2023. He will report to CEO Gary S. Guthart, who will relinquish the President title but remain CEO and a board member. This promotion signifies a strategic move to leverage Mr. Rosa's extensive experience in commercial, scientific, and strategic roles within the company since 1996. In conjunction with his new role, Mr. Rosa will receive a salary increase to $700,000 and an enhanced bonus target of 120% of his base salary for fiscal year 2023. Additionally, he has been granted significant equity awards, including stock options, RSUs, and PSUs, valued at $1.5 million, $1.5 million, and $2 million, respectively. These awards are designed to align his compensation with long-term company performance and shareholder value. The appointment suggests a continued focus on growth and operational leadership within Intuitive Surgical.
INTUITIVE SURGICAL INC 8-K Report, Shareholder Vote Results (May 2, 2023)
Intuitive Surgical, Inc. (ISRG) filed an 8-K report detailing the outcomes of its Annual Meeting of Stockholders held on April 26, 2023. The report confirms that all key proposals presented to shareholders received strong support, indicating alignment between management and its investors on critical governance matters. Notably, all eleven director nominees were elected, and the company's executive compensation plan was approved on an advisory basis, with shareholders preferring an annual frequency for such votes going forward. The ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2023 also passed overwhelmingly, reinforcing confidence in the company's financial oversight. However, a shareholder proposal concerning pay equity disclosure was not approved. Overall, the filing suggests a stable and supportive shareholder base for the company's current leadership and financial reporting practices.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 18, 2023)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on April 18, 2023, to announce its financial results for the first quarter ended March 31, 2023. The company furnished a press release (Exhibit 99.1) detailing these results. Investors should note that the information provided in this filing is furnished and not deemed "filed" for the purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities and is not automatically incorporated into future filings unless explicitly stated. While the full details of the financial results are within the furnished press release (Exhibit 99.1), the core purpose of this 8-K filing is to make these Q1 2023 earnings publicly accessible. Investors seeking specific financial metrics such as revenue, net income, earnings per share, and operational highlights (e.g., system placements, procedure volumes) will need to refer to the press release itself.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 24, 2023)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on January 24, 2023, primarily to furnish a press release announcing its financial results for the fourth quarter and full year ended December 31, 2022. While the 8-K itself does not contain the detailed financial data, it directs investors to the furnished press release (Exhibit 99.1) for this crucial information. Investors should consult this press release for specific figures related to revenue, profit, system placements, and procedure growth, which are key performance indicators for ISRG.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 11, 2023)
Intuitive Surgical, Inc. (ISRG) has filed a Form 8-K to report preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2022. The filing includes a press release and tables detailing revenue and procedure information, which are furnished as exhibits and available on the company's investor relations website. While these results are preliminary and not yet finalized, they provide early insights into the company's performance for the period.
INTUITIVE SURGICAL INC 8-K Report, Corporate Update (Oct 25, 2022)
Intuitive Surgical, Inc. (ISRG) announced on October 24, 2022, that it has entered into an accelerated share repurchase (ASR) agreement with Citibank, N.A., to repurchase an aggregate of $1 billion of its common stock. Under the terms of the agreement, ISRG will make an initial payment of $1 billion and will receive an initial delivery of approximately 3.6 million shares. The final number of shares repurchased will be determined based on the volume-weighted average price during the repurchase period, with final settlement expected in late December 2022. This significant share repurchase program signals management's confidence in the company's valuation and its commitment to returning capital to shareholders. Investors should view this ASR as a positive indicator, suggesting that the company believes its stock is undervalued and that it anticipates strong future performance. The repurchase is expected to reduce the number of outstanding shares, potentially boosting earnings per share (EPS) and overall shareholder value.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 18, 2022)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on October 18, 2022, primarily to furnish a press release detailing its financial results for the third quarter ended September 30, 2022. While the specific financial figures are within the furnished press release (Exhibit 99.1), this 8-K filing itself acts as notification of these results becoming public. Investors should refer to the press release for comprehensive details on revenue, profitability, procedure volumes, and any forward-looking guidance provided by the company. The significance of this filing lies in its role as an official channel for disseminating quarterly financial performance. Investors and analysts will be scrutinizing the press release for key metrics that reflect the company's growth trajectory, operational efficiency, and market position in robotic-assisted surgery. Any deviations from expectations, positive or negative, regarding procedure growth, instrument and accessory sales, or system placements will be critical for assessing the company's ongoing performance and future outlook.
INTUITIVE SURGICAL INC 8-K Report, Corporate Update (Aug 2, 2022)
Intuitive Surgical, Inc. (ISRG) announced on August 1, 2022, that it has entered into an Accelerated Share Repurchase (ASR) agreement with Goldman Sachs & Co. LLC to buy back $1 billion of its common stock. Under this agreement, the company will pay $1 billion upfront and will receive an initial delivery of approximately 3.5 million shares. The final number of shares repurchased will be determined based on the volume-weighted average price during the repurchase period, with potential adjustments at settlement. This significant capital return to shareholders signals management's confidence in the company's financial health and its stock valuation. Investors should note that the ASR is expected to conclude in approximately three months, though it may be accelerated. The terms include mechanisms for determining the final share count and potential adjustments, highlighting the complexity of such transactions. While the company expects to repurchase a substantial amount of stock, the exact number of shares will be subject to market conditions and the terms of the ASR.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 21, 2022)
Intuitive Surgical, Inc. (ISRG) announced its financial results for the second quarter ended June 30, 2022, via a press release filed on July 21, 2022. This filing primarily serves to furnish the press release detailing these results, making it accessible to investors. While the 8-K itself doesn't contain the specific financial figures, it directs stakeholders to the comprehensive press release for this crucial information. Investors should refer to the furnished press release (Exhibit 99.1) for detailed insights into ISRG's revenue, profitability, procedural volumes, and any forward-looking guidance provided for the quarter. This announcement is a key event for understanding the company's operational performance and financial health during the period.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (May 3, 2022)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on May 2, 2022, reporting on outcomes from its Annual Meeting of Stockholders held on April 28, 2022. The primary focus of the filing is the stockholder approval of the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. This amendment increases the number of shares reserved for issuance under the plan and extends its term to 2032, indicating a continued commitment to equity-based compensation for employees and executives. Additionally, the filing provides details on the voting results for other key proposals presented at the Annual Meeting. All eleven director nominees were elected to serve a one-year term, and the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2022 was ratified. The compensation of Named Executive Officers was also approved on an advisory basis, signaling continued shareholder confidence in the company's leadership and governance practices.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 21, 2022)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on April 21, 2022, to announce its first-quarter financial results for the period ended March 31, 2022. The key takeaway from this filing is the release of their earnings press release, which provides investors with detailed performance metrics and financial condition updates for the quarter. While the 8-K itself does not contain the full financial statements, it directs readers to the furnished press release (Exhibit 99.1) for comprehensive information. Investors should review the press release for crucial data points such as revenue growth, procedure volumes, robot system placements, and profitability. The filing emphasizes that the information provided, including the press release, is furnished and not deemed 'filed' for liability purposes under Section 18 of the Exchange Act. This means the company is providing information to the public but not assuming the same level of legal responsibility as if it were part of a formal registration statement or periodic report.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 20, 2022)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on January 20, 2022, to announce its financial results for the fourth quarter and full year ended December 31, 2021. While the 8-K itself doesn't contain detailed financial figures, it directs investors to a press release (Exhibit 99.1) for this information. This filing serves as the official notification of the release of their quarterly earnings, which is a critical event for investors to assess the company's recent performance and future outlook.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 12, 2022)
Intuitive Surgical, Inc. (ISRG) has filed an 8-K report on January 12, 2022, to disclose preliminary, unaudited financial results for the fourth quarter and full year ended 2021. This filing provides investors with early insight into the company's performance, ahead of a more detailed financial report. The press release and supplementary tables, furnished as exhibits, contain key operational and financial metrics. The preliminary results are expected to cover revenue figures and procedure volumes, which are crucial indicators for the company's growth trajectory and market adoption of its robotic surgical systems. Investors should pay close attention to these updates for a sense of the company's momentum entering 2022, especially given the ongoing dynamics in the healthcare sector.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 19, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on October 19, 2021, reporting on two key areas: financial results for the quarter ended September 30, 2021, and significant executive leadership changes. While the specifics of the financial results are detailed in an accompanying press release (Exhibit 99.1), the filing confirms that these results were announced on October 19, 2021. Investors should refer to this press release for detailed financial performance metrics. Furthermore, the company announced the appointment of Jamie Samath as Chief Financial Officer (CFO), effective January 1, 2022. Mr. Samath has a strong internal track record, having joined ISRG in 2013 and progressively moved into senior finance roles. Additionally, Fredrik Widman will assume the role of Principal Accounting Officer, also effective January 1, 2022, while continuing as Vice President, Corporate Controller. These leadership transitions are important for understanding the continuity and direction of the company's financial management.
INTUITIVE SURGICAL INC 8-K Report, Shareholder Vote Results (Sep 23, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on September 22, 2021, reporting the results of a Special Meeting of Stockholders held on September 20, 2021. The primary purpose of this meeting was to vote on a proposal to amend the Company's Certificate of Incorporation to increase the number of authorized common shares from 300,000,000 to 600,000,000. This increase is primarily intended to facilitate a three-for-one stock split.
INTUITIVE SURGICAL INC 8-K Report, Corporate Update (Aug 5, 2021)
Intuitive Surgical, Inc. (ISRG) announced on August 5, 2021, that its Board of Directors has approved a proposal for a three-for-one stock split, subject to shareholder approval. This corporate action will increase the number of authorized common shares from 300,000,000 to 600,000,000. The stock split is intended to make the company's common stock more accessible to a broader range of investors and to provide greater flexibility for future corporate actions. Shareholders will vote on this proposal at a Special Meeting scheduled for September 20, 2021. Investors are encouraged to review the forthcoming proxy statement for detailed information regarding the proposal and voting procedures.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 20, 2021)
Intuitive Surgical, Inc. (ISRG) announced its financial results for the quarter ended June 30, 2021, on July 20, 2021, via a press release. This 8-K filing primarily serves to furnish that press release, which contains the detailed operational and financial performance for the period. Investors should refer to the press release (Exhibit 99.1) for comprehensive details on the company's performance, as the 8-K itself does not provide specific financial figures or operational commentary beyond referencing the press release. The information furnished in this report is not considered "filed" for purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as a formally filed document. However, it is a crucial point of reference for understanding Intuitive Surgical's recent financial outcomes and is intended to be incorporated into investor understanding of the company's standing.
INTUITIVE SURGICAL INC 8-K Report, Executive Changes (Apr 26, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on April 26, 2021, detailing key governance and shareholder decisions made at their Annual Meeting on April 22, 2021. The most significant event for investors is the stockholder approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan. This amendment increases the number of shares reserved for awards, extends the plan's term, and modifies dividend payout conditions, all of which are crucial for understanding future equity compensation and potential dilution. The filing also confirms the election of eleven directors to the Board and the advisory approval of executive compensation. Additionally, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2021 was ratified. These routine governance items provide ongoing assurance to investors regarding corporate oversight and financial reporting.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Apr 20, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on April 20, 2021, primarily to announce its financial results for the first quarter ended March 31, 2021. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for this information. This is a standard procedure for companies to disseminate quarterly earnings promptly after market close or before market open. Investors should refer to the press release dated April 20, 2021, for crucial details regarding ISRG's performance in Q1 2021. This includes key financial metrics such as revenue, earnings per share, system placements, and procedure volumes, which are vital for assessing the company's operational and financial health, as well as its trajectory in the robotic-assisted surgery market.
INTUITIVE SURGICAL INC 8-K Report, Bylaw Amendment (Feb 1, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on February 1, 2021, primarily to announce amendments to its corporate bylaws. The key change involves the adoption of a forum selection bylaw. This bylaw designates the Court of Chancery of the State of Delaware (or federal courts in Delaware if necessary) as the exclusive venue for a broad range of internal corporate claims, including derivative actions and breaches of fiduciary duty. Additionally, federal district courts in the U.S. are designated as the exclusive forum for claims arising under the Securities Act of 1933. This amendment aims to centralize and streamline litigation concerning the company, potentially reducing legal costs and providing greater predictability in how such disputes are handled.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 21, 2021)
Intuitive Surgical, Inc. (ISRG) has filed a Form 8-K on January 21, 2021, to report its financial results for the fourth quarter and full year ended December 31, 2020. The filing primarily serves to furnish a press release containing these results, which was issued on the same date. Investors should note that the information furnished in this report, including the press release, is not considered "filed" under Section 18 of the Exchange Act and therefore does not carry the same liabilities. This means the information is provided for informational purposes without the same regulatory implications as a formally filed document.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jan 13, 2021)
Intuitive Surgical, Inc. (ISRG) filed an 8-K report on January 13, 2021, to announce preliminary unaudited financial results for the fourth quarter and full year ended 2020. The filing includes a press release and additional tables detailing preliminary revenue and procedure information. Investors should note that this information is preliminary and furnished, not filed, meaning it's not subject to the full liabilities of Section 18 of the Exchange Act. The primary purpose of this report is to provide investors with an early look at the company's performance heading into the new year, prior to the official earnings release.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Oct 15, 2020)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on October 15, 2020, to announce its financial results for the third quarter ended September 30, 2020. The report primarily consists of a press release detailing these results. While the 8-K itself is brief, the furnished press release is the key document for investors seeking performance insights from this filing. Investors should refer to the press release (Exhibit 99.1) for specific financial metrics and operational updates. This filing serves as an update to the market on ISRG's performance. The company is providing its quarterly financial results through a press release, which is standard practice for publicly traded companies. Investors will be looking for key performance indicators such as revenue, profit margins, procedure volumes, and any forward-looking statements or guidance that might be included in the press release. The disclaimer within the 8-K clarifies that the information furnished is not deemed "filed" for certain regulatory purposes, which is a common provision.
INTUITIVE SURGICAL INC 8-K Report, Financial Results (Jul 21, 2020)
Intuitive Surgical, Inc. (ISRG) filed an 8-K on July 21, 2020, to report its financial results for the second quarter ended June 30, 2020. The press release, furnished as Exhibit 99.1, provides key operational and financial metrics for the period. Investors should note that this information is furnished and not deemed 'filed' under the Securities Exchange Act of 1934, meaning it does not automatically become part of future SEC filings without specific incorporation. The primary focus of this filing is the dissemination of the company's quarterly performance. While the full details are within the press release, this 8-K serves as the official notification mechanism for investors to access these important financial updates, enabling them to assess the company's recent performance and outlook.